Literature DB >> 23177910

Efficacy of a formalin-killed cell vaccine against infectious spleen and kidney necrosis virus (ISKNV) and immunoproteomic analysis of its major immunogenic proteins.

Chuanfu Dong1, Xiaopeng Xiong1, Yongwen Luo1, Shaoping Weng1, Qing Wang1, Jianguo He2.   

Abstract

Infectious spleen and kidney necrosis virus (ISKNV), the type species of genus Megalocytivirus in the family Iridoviridae, is the most important etiological agents in mandarin fish industry in China. Since its first occurrence in China in the early 1990s, there is no effective method to prevent and control this virus. Here we report the successful development of a formalin-killed cell-cultured (FKC) vaccine again ISKNV. Immuno-protection experiments showed that greater than 90% of fish immunized with the FKC vaccine were protected against virulent ISKNV. Sera derived from the immunized fish markedly inhibited the virus infection both in vitro and in vivo. Purified IgM from the immunized fish sera also showed efficient neutralization effects in vivo, strongly suggesting that antibody-mediated immunity may play an important role in the FKC vaccine. Using FKC-immunized fish sera as first antibody, a two-dimensional gel electrophoresis mass spectrometry analysis-based immuno-proteomic method was performed to identify the immunogenic proteins. ORF006L (the major capsid protein), ORF054L, ORF055L, ORF101L, ORF117R, and ORF125R were found to be the major immunogenic proteins of ISKNV. Antibodies generated from these six recombinant viral proteins were able to recognize specifically the corresponding protein fractions from purified virions by Western blot analysis, and five of them (excluding ORF125) showed positive reactions by indirect immunofluorescence assay. In summary, the present study first developed an effective vaccine against ISKNV, and the major immunogenic proteins of ISKNV are also identified. The reported ISKNV immunogenic proteins are important for further development of diagnostic regents and genetic vaccine candidates for all megalocytivirus.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177910     DOI: 10.1016/j.vetmic.2012.10.026

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

1.  Cloning of a new fibroblast cell line from an early primary culture from mandarin fish (Siniperca chuatsi) fry for efficient proliferation of megalocytiviruses.

Authors:  Chuanfu Dong; Fan Shuang; Shaoping Weng; Jianguo He
Journal:  Cytotechnology       Date:  2013-10-08       Impact factor: 2.058

2.  PCR Detection and Phylogenetic Analysis of Megalocytivirus Isolates in Farmed Giant Sea Perch Lates calcarifer in Southern Taiwan.

Authors:  Jia-Ming Tsai; Song-Lang Huang; Chung-Da Yang
Journal:  Viruses       Date:  2020-06-24       Impact factor: 5.048

3.  Scale Drop Disease Virus Associated Yellowfin Seabream (Acanthopagrus latus) Ascites Diseases, Zhuhai, Guangdong, Southern China: The First Description.

Authors:  Yuting Fu; Yong Li; Weixuan Fu; Huibing Su; Long Zhang; Congling Huang; Shaoping Weng; Fangzhao Yu; Jianguo He; Chuanfu Dong
Journal:  Viruses       Date:  2021-08-16       Impact factor: 5.048

4.  Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach.

Authors:  Sk Injamamul Islam; Moslema Jahan Mou; Saloa Sanjida; Muhammad Tariq; Saad Nasir; Sarower Mahfuj
Journal:  Genomics Inform       Date:  2022-03-31

5.  Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection.

Authors:  Ruoyun Zeng; Weiqiang Pan; Yifan Lin; Jian He; Zhiyong Luo; Zhimin Li; Shaoping Weng; Jianguo He; Changjun Guo
Journal:  iScience       Date:  2021-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.